Conflict of Interest Disclosures

Editor-In-Chief

Pamela Hallquist Viale, RN, MS, CNS, ANP, has no conflicts of interest to disclose.

Associate Editors

Jeannine M. Brant, PhD, APRN, AOCN®, has served on speakers bureaus for Genentech and Insys Therapeutics.

Christopher J. Campen, PharmD, BCOP, has received honoraria from Agios, Astellas Pharma, and Teva Pharmaceutical Industries.

Beth Eaby-Sandy, MSN, CRNP, OCN®, has served on speakers bureaus for AbbVie, AstraZeneca, Helsinn, Merck, and Takeda.

Denice Economou, RN, MN, CNS, AOCN®, CHPN, has no conflicts of interest to disclose.

Theresa Wicklin Gillespie, PhD, MA, RN, has no conflicts of interest to disclose.

Carolyn Grande, CRNP, AOCNP®, has served as a consultant for AstraZeneca and Pfizer.

Sandra E. Kurtin, PhD, ANP-C, AOCN®, has served as a consultant for AbbVie, Acceleron, Amgen, Celgene, Genentech, Incyte, Novartis, and Pharmacyclics.

Lindsey Lyle, MS, PA-C, has served as a consultant for Agios, Celgene, Incyte Corporation, Novartis, Takeda Oncology, and Pfizer.

Lydia T. Madsen, PhD, RN, AOCNS®, has no conflicts of interest to disclose.

Constance Visovsky, PhD, RN, ACNP-BC, has no conflicts of interest to disclose.

Wendy H. Vogel, MSN, FNP, AOCNP®, has served as a network speaker for AMAG, Amgen, Celgene, Genentech, Ipsen, Janssen, Novartis, and Pfizer.

Steven H. Wei, MS, MPH, PA-C, has no conflicts of interest to disclose.

Rita Wickham, PhD, RN, AOCN®, has served on the speakers bureau for Genentech and as a consultant for Insys Therapeutics.